To be honest, the reasoning process turned out better than I expected. The future belongs to AI. My analysts might be out of a job soon.$XTALPI(02228.HK)

Alright, I'll first clarify "what exactly is going on," then provide you with an actionable observation framework and trend analysis. The following conclusions are based on real-time market and announcement data I've retrieved.

Conclusion First

Over the last 4 trading days (8/6, 8/7, 8/8, 8/11), the total trading volume was approximately 1.587 billion shares, almost turning over the entire free float (≈100%). This is a super turnover:
8/6: 799 million; 8/7: 360 million; 8/8: 160 million; 8/11: 268 million. (MarketScreener, FT Markets)

The immediate trigger was the early August announcement of a nearly $6 billion AI drug collaboration with DoveTree (including a $51 million upfront payment, milestones, and royalties), which led to revised expectations and event-driven capital inflows. (Morningstar, Sina Finance)

The price path was: On 8/6, a massive surge to near the previous high of 8.10 → High-volume turnover on 8/7–8 → Another volume rebound on 8/11. This resembles "post-news redistribution of chips" rather than pure selling or pumping. (MarketScreener, FT Markets)

Data Review

How Big Was the "Massive Volume" Over the Last 4 Days?

The total volume over the last 4 days was 1,587,471,200 shares (sum of the four days). This is equivalent to:

~39.5% of total shares outstanding (issued shares: ~4.02 billion). (hk.stockstar.com)

~101% of the free float (free float ratio: ~39.22%), meaning almost all floating shares were turned over. (MarketScreener)

The 20-day average volume was ~158 million shares, so the 799 million shares on 8/6 were ~5x the 20-day average, an extreme volume spike. (MarketScreener)

Trend and Position Over the Last 6 Months

From the Q2 low this year: 6/2 low of ~HK$4.48 → Mid-July rebound to ~HK$6 → Early August surge to the 8.10 high, currently ~HK$7.45. (StockAnalysis, FT Markets)

3-month gain: ~+55.8%, 6-month: ~+10.9%; Year-to-date high: ~HK$8.55, with the 8/6 intraday high of 8.10 nearing the previous high zone. (MarketScreener)

Moving averages: 5/20/50/100-day averages at 6.92/6.25/5.79/5.45, with the current price still above major averages, indicating an intact trend structure. (MarketScreener)

Why the "Explosive Volume" Near the Previous High?

Fundamental/Order-Driven Expectation Revision
The DoveTree collaboration in August was large and had clear terms (upfront + milestones). The market often views such deals as signals of commercialization and cash flow improvement, attracting event-driven and trend-following capital. (Morningstar, Sina Finance)

Changes in Existing Share Structure
The company raised over HK$3 billion in two placements earlier this year (January: ~HK$1.13 billion, February: ~HK$2.09 billion; February placement price: HK$6.10, up to 342.288 million shares), which objectively increased market liquidity, making it easier for extreme turnover to occur amid major news. (Sina Finance)

Technical "Consensus"
The 8/6 surge to 8.10 neared the year-to-date high of 8.55, triggering 1) momentum chasing and 2) profit-taking/position adjustments near the high. This explains the high volume but pullback the next day (typical high-turnover consolidation, not a "top-out" signal). (MarketScreener)

Background note: The company is still in a high-investment phase, with 2024 revenue of ~HK$266 million and a net loss exceeding HK$1.5 billion. There is a "gap" between news-driven price action and long-term fundamentals. (Sina Finance)

What’s Next? (Trading/Trend Outlook)

I’ve divided the short-to-medium term into three scenarios with corresponding watch levels:

A. Consolidation (Baseline, ≈40%)

Logic: After super turnover, prices typically oscillate between the 5-day/20-day averages as capital awaits further earnings/contract updates.

Watch levels: 7.0–7.2 (near 5-day average) and 6.2–6.3 (20-day average). Holding either level with reduced volume and stabilization signals healthy digestion. (MarketScreener)

B. Breakout (Optimistic, ≈35%)

Trigger: Volume retreats to near the 20-day average, then surges again to break 8.10 and challenge the year-to-date high of 8.55.

Key: A breakout with volume ≥2×20-day average is more reliable. Only a sustained move above 8.55 would open further upside. (MarketScreener)

C. Pullback (Cautious, ≈25%)

Trigger: Continued high volume but price falls below the 20-day average (~6.25) and closes lower, signaling supply > demand.

Potential target: The June consolidation zone of 5.8–6.0. If volume-price declines persist, the trend shifts from "strong consolidation" to "correction." (StockAnalysis, MarketScreener)

Quick Reference Table

Event Drivers: Watch for further collaboration updates/milestone payments (beyond DoveTree, the company expanded its partnership with Pfizer on 6/30). (XtalPi)

Volume Threshold: Compare to the 20-day average of ~158 million shares. Future breakouts/breakdowns should be accompanied by "multiples of average volume." (MarketScreener)

Key Levels: 8.10 / 8.55 (resistance), 7.0–7.2 / 6.2–6.3 (support). (MarketScreener)

Share Structure: Total shares ~4.02 billion, free float ~39%. The 4-day turnover ≈39% of total shares/100% of free float, indicating full redistribution. Future direction depends on which capital takes control. (hk.stockstar.com, MarketScreener)

Fundamental Constraint: The company is still loss-making (2024 net loss: ~HK$1.5 billion), so beware of the "good news - high valuation - pullback" cycle. (Sina Finance)

If you'd like, I can compile the daily price/volume, moving averages, volume thresholds, and key events over the last six months into a one-page summary (table/graph) for you to use as a "signal guide." Let me know if you prefer a chart or table, and I’ll generate it.
(The above is for market research and data analysis only, not investment advice.)